Biohaven (BHVN) Misses on Q3 Earnings, Inks $1.24B Pfizer Deal

Biohaven’s (BHVN) sole approved drug, Nurtec ODT, for treating migraine, continues to demonstrate strong demand in the United States. The company signs an agreement with Pfizer, granting the latter ex-U.S….

Leave a comment

Your email address will not be published. Required fields are marked *